You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 6, 2025

Drug Price Trends for NDC 00121-0721


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00121-0721

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
FLUOXETINE HCL 20MG/5ML SOLN,ORAL Golden State Medical Supply, Inc. 00121-0721-04 118ML 19.49 0.16517 2023-06-15 - 2028-06-14 FSS
FLUOXETINE HCL 20MG/5ML SOLN,ORAL Golden State Medical Supply, Inc. 00121-0721-04 118ML 20.81 0.17636 2023-06-23 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

00121-0721 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 00121-0721

Understanding NDC Numbers

Before diving into the market analysis and price projections for a specific drug identified by its National Drug Code (NDC), it's crucial to understand what NDC numbers represent. NDC numbers are unique identifiers for medications, consisting of three segments: the labeler code, the product code, and the package code. These numbers are vital for tracking, regulatory compliance, and inventory management in the pharmaceutical industry[1].

Identifying the Drug

To conduct a market analysis and price projection for the drug with the NDC number 00121-0721, we first need to identify the drug. However, the provided sources do not specify the drug associated with this NDC number. Typically, you would refer to the FDA's National Drug Code Directory or similar databases to identify the drug[5].

General Market Trends in Pharmaceuticals

Given the lack of specific data on the drug with NDC 00121-0721, we can discuss general market trends and factors that influence price projections in the pharmaceutical industry.

Price Increases and Trends

Prescription drug prices often see significant increases, particularly in January and July of each year. According to recent analyses, the number of price increases has been higher in these months, with average price increases ranging from 7.8% to 10.0% in 2022. These increases can be substantial, with some drugs experiencing price hikes of over $20,000 or more than 500%[2].

Regulatory and Market Factors

Several factors influence the pricing and market performance of pharmaceuticals:

Regulatory Compliance

Pharmaceutical companies must comply with FDA regulations, which include the use of NDC numbers for labeling, packaging, and billing claims. Non-compliance can result in penalties and legal consequences, affecting the market performance of the drug[1].

Supply Chain Optimization

NDC numbers play a crucial role in optimizing supply chains by facilitating standardized communication between suppliers, manufacturers, distributors, and pharmacies. This helps in streamlining the procurement process and reducing lead times, which can impact the availability and pricing of the drug[1].

Market Demand and Competition

The demand for a drug and the level of competition in its therapeutic area significantly impact its pricing. For example, in the Non-Small Cell Lung Cancer (NSCLC) market, the introduction of premium-priced immunotherapies has driven market growth, with drugs like Keytruda, Opdivo, and Tecentriq achieving blockbuster status[4].

Price Projections

To make accurate price projections for a specific drug, several factors need to be considered:

Historical Price Data

Analyzing historical price data for the drug and similar products in the same therapeutic area can provide insights into potential future price trends.

Market Growth and Incidence Rates

For diseases like NSCLC, the increasing incidence rates and the uptake of branded therapies can drive market growth and influence pricing. For instance, the NSCLC market is expected to grow significantly due to the increasing incidence of the disease and the adoption of premium-priced therapies[4].

Regulatory and Patent Considerations

Patent expirations and the introduction of generics can significantly impact the pricing of a drug. For example, the patent expiration of blockbuster drugs like Tarceva and Alimta has led to a decline in their sales as generics enter the market[4].

Technological and Clinical Advancements

Advancements in clinical trial designs, precision medicine, and the use of AI/ML technologies can reshape the pharmaceutical industry and influence pricing strategies. For instance, accelerated clinical trial designs and evolving regulatory frameworks are expected to impact drug development and pricing in the biopharma and biotech industries[3].

Example: NSCLC Market Analysis

In the NSCLC market, the introduction of immunotherapies has significantly driven market growth. Here are some key points:

  • Immunotherapies: Drugs like Keytruda, Opdivo, and Tecentriq are projected to reach $17.5 billion in sales by 2025, accounting for roughly 65% of the total NSCLC market sales[4].
  • Incidence Rates: The increasing incidence of NSCLC, particularly in urban China, is expected to drive market growth. The incidence is forecast to increase at an Annual Growth Rate (AGR) of 3.1% from 2015 to 2025[4].
  • Generic Erosion: The entry of generics, such as biosimilar bevacizumab, is expected to impact the sales of branded drugs like Avastin, leading to a decline in their market share[4].

Key Takeaways

  • NDC Numbers: Crucial for tracking, regulatory compliance, and inventory management in the pharmaceutical industry.
  • Price Trends: Significant price increases often occur in January and July, with average increases ranging from 7.8% to 10.0%.
  • Market Factors: Demand, competition, regulatory compliance, and technological advancements influence pricing and market performance.
  • Regulatory Considerations: Patent expirations and the introduction of generics can significantly impact pricing.
  • Market Growth: Increasing incidence rates and the adoption of premium-priced therapies drive market growth in specific therapeutic areas.

FAQs

1. What is the significance of NDC numbers in the pharmaceutical industry? NDC numbers provide a standardized way to identify and track medications, ensuring accurate tracking, regulatory compliance, and optimized supply chain management[1].

2. How often do prescription drug prices increase? Prescription drug prices often see significant increases, particularly in January and July of each year[2].

3. What factors influence the pricing of pharmaceuticals? Factors include market demand, competition, regulatory compliance, patent considerations, and technological advancements[1][4].

4. How do generics impact the pricing of branded drugs? The entry of generics can lead to a decline in the market share and sales of branded drugs, as seen in the NSCLC market with the introduction of biosimilar bevacizumab[4].

5. What role do NDC numbers play in optimizing supply chains? NDC numbers facilitate standardized communication between suppliers, manufacturers, distributors, and pharmacies, helping to streamline the procurement process and reduce lead times[1].

Sources

  1. Quality Smart Solutions - Why NDC Numbers are vital for pharmaceutical companies?
  2. ASPE - Price Increases for Prescription Drugs, 2016-2022
  3. TFS CRO - 5 Predictions for the Biopharma and Biotech Industries in 2025
  4. GlobalData - NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025
  5. HealthData.gov - National Drug Code Directory

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.